Eric Wiedower, DO¹, Smith Giri, MBBS², Andrew Fintel, DO³, Philip Prouet, MD^4*, Elena Paulus, MD^5*, Jason C. Chandler, MD⁶ and Mike G. Martin, MD⁶

¹Division of Hematology/Oncology, Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
²Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
³Hematology/Oncology Fellow, University of Tennessee Health Science Center, Memphis, TN
⁴Internal Medicine, University of Tennessee Health Science Center, Memphis, TN
⁵Surgery Resident, University of Tennessee Health Science Center, Memphis, TN
⁶Hematology/Oncology, The West Cancer Center/The University of Tennessee Health Science Center, Memphis, TN

Ashley D. Staton, MD¹, Qiushi Chen^2*, Turgay Ayer, PhD^2*, Daniel Goldstein, MD^1*, Jean L. Koff, MD^1* and Christopher R. Flowers, MD¹

¹Winship Cancer Institute, Emory University, Atlanta, GA
²Georgia Institute of Technology, Atlanta, GA

Mauricette Michallet, MD, PhD, Mohamad Sobh, PharmD^*, Jeremy Monfray, CRA^*, Hélène Labussière-wallet, MD^*, Marie Balsat, MD^*, Caroline Lejeune, MD^*, Sophie Ducastelle-Leprêtre, MD^*, Fiorenza Barraco, MD^*, Xavier Thomas and Franck E. Nicolini, MD, PhD

Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France

Anna O. D'Souza, B.Pharm, PhD^1*, Dinara Makenbaeva, MD, MBA^2*, Eileen Farrelly, MPH^1*, Pamela Landsman-Blumberg, MPH, DrPH^1* and Bjorn Bolinder, MSc, MBA^3*

¹Applied Data Analytics, Xcenda, Palm Harbor, FL
²Hematology, Bristol-Myers Squibb, Plainsboro, NJ
³Bristol-Myers Squibb Company, Plainsboro, NJ

Ashley T Freeman, MD^1*, Anne Marie Meyer, PhD^2*, Andrew B Smitherman, MD^3*, Lei Zhou, MSPH^2*, Ethan M Basch, MD, MSc^1*, Thomas C. Shea, MD⁴ and William A. Wood, MD, MPH⁵

¹Division of Hematology / Oncology, University of North Carolina, Chapel Hill, NC
²Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC
³Division of Pediatric Hematology / Oncology, University of North Carolina, Chapel Hill, NC
⁴Department of Medicine, University of North Carolina, Chapel Hill, NC
⁵Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

Matthew J. Ehrhardt, MD, MS^1,2, Daniel A. Mulrooney, MD, MS^1,2, Chenghong Li, PhD^3*, John T. Sandlund, MD¹, Tara M. Brinkman, PhD^2,4*, I-Chan Huang, PhD^2*, DeoKumar Srivastava, PhD^3*, Kirsten K. Ness, PhD^2*, Leslie L. Robison, PhD, MPH², Melissa M. Hudson, MD^1,2 and Kevin R. Krull, PhD^2,4*

¹Oncology, St. Jude Children's Research Hospital, Memphis, TN
²Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
³Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
⁴Psychology, St. Jude Children's Research Hospital, Memphis, TN

Amit Patel, MBBS, PhD, MRCP, MRCS, FRCPath^1,2*, Thomas Stroud, BSc^3*, Danielle Breen^3*, Ala Taifoor^3*, Anne Bradshaw^4*, Richard Szydlo, PhD^2*, Jonathan WA Ramsay, MBBS, MS, FRCS(Urol)^3,5*, Stephen R Bloom, MBBChir, MA, MD, DSc, FRCP, FRCPath, FMedSci, FSB, FRS^6*, Waljit S Dhillo, MBBS, PhD, FRCP, FRCPath, FHEA^6* and Channa N Jayasena, MBBChir, MA, PhD, MRCP, FRCPath^3,6*

¹Targeted Therapy, Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom
²Centre for Haematology, Imperial College London, London, United Kingdom
³Andrology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁴Centre for Haematology, Hammersmith Hospital, Imperial College NHS Healthcare Trust, London, United Kingdom
⁵Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁶Section of Investigative Medicine, Imperial College London, London, United Kingdom

Britton Keeshan, MD, MPH^1*, Kimberly Y Lin, MD^2*, Matthew J O'Connor, MD^2*, Jill P Ginsberg, MD^3*, Richard Aplenc, MD, PhD³, Robert Shaddy, MD^2* and Joseph Rossano, MD^2*

¹Pediatric Cardiology, Seattle Children's Hospital, Seattle, WA
²Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA
³Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA

Anthony Mato, MD^1*, Chadi Nabhan, MD², Christopher Flowers, MD³, Neil E. Kay, MD⁴, Thomas J. Kipps, M.D., PhD.⁵, David L. Grinblatt, MD⁶, Nicole Lamanna, MD⁷, Mark Kozloff, MD^8*, Kristen Sullivan^9*, E. Dawn Flick, RPh, MPH, ScD^10*, Pavel Kiselev, PhD^11*, Shriya Bhushan, PharmD^11*, Arlene S. Swern, PhD^11* and Jeff P. Sharman, MD¹²

¹Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL
³Winship Cancer Institute of Emory University, Atlanta, GA
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁶NorthShore University HealthSystem, Evanston, IL
⁷Columbia University Medical Center, New York, NY
⁸Ingalls Cancer Research Center, Harvey, IL
⁹Celgene Corporation, Overland Park, KS
¹⁰Celgene Corporation, South San Francisco, CA
¹¹Celgene Corporation, Summit, NJ
¹²Willamette Valley Cancer Institute, Springfield, OR

Smith Giri, MBBS¹, Nunnery Sara^2*, Syed S. Nasir^2* and Michael G Martin, MD³

¹Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
²University of Tennessee Health Science Center, Memphis, TN
³Hematology/Oncology, The West Cancer Center/The University of Tennessee Health Science Center, Memphis, TN

Tanya M Wildes, MD, MSCI¹, Mark A Fiala, BS, CCRP^1*, Ashley E Rosko, MD², Sascha Tuchman, MD³, Emily Guerard, MD^4*, Elizabeth K. O'Donnell, MD⁵, Erica L. Campagnaro, MD⁶, Keith Stockerl-Goldstein, MD¹ and Ravi Vij, MD, MBA¹

¹Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
²Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
³Duke University, Durham, NC
⁴UNC Chapel Hill, Chapel Hill, NC
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶University of Michigan, Ann Arbor, MI

Indumathy Varadarajan, MD¹, Parshva Patel, MD^2*, Ravindra Sangitha, BS^3*, Kristine Ward, MD⁴, Maneesh Jain, MD⁴ and Michael Styler, MD⁵

¹Hematology Oncology, Drexel University, Philadelphia, PA
²Drexel College of Medicine, Drexel University-Hahenmann Hospital, Philadelphia, PA
³Hematology Oncology, Drexel University College of Medicine, Philadelphia, PA
⁴Drexel University College of Medicine, Philadelphia, PA
⁵Drexel Unviersity College of Medicine, Philadelphia, PA

Isabelle Borget, PharmD, PhD^1*, Florian Scotte, MD, PhD^2*, Nicolas Martelli, PharmD, PhD^3*, Alexandre Vainchtock^4* and Ismail Elalamy, MD, PhD⁵

¹Institut Gustave Roussy, Villejuif, France
²Hopital Européen Georges Pompidou, Paris, France
³Hôpital Européen Georges Pompidou, Paris, France
⁴HEVA Institute, Lyon, France
⁵Service d’Hématologie Biologique Hôpital Tenon, Hôpitaux Universitaires de l’Est Parisien, Assistance Publique Hôpitaux de Paris, Paris, France

Natalie S. Grover, MD^1*, Allison M. Deal, MS^2*, Jennifer E. Mersereau, MD, MSCI^3* and William A. Wood, MD, MPH⁴

¹Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC
²Biostatistics and Clinical Data Management Core, University of North Carolina, Chapel Hill, NC
³Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

Sarah K. Dobrozsi, MD, MS¹, Ke Yan, PhD^2*, Raymond G. Hoffmann, PhD^3* and Julie A. Panepinto, MD, MSPH⁴

¹Pediatrics, Medical College of Wisconsin, Milwaukee, WI
²Medical College of Wisconsin, Milwaukee, WI
³Department of Pediatrics, Division of Quantitative Health Sciences, Medical College of Wisconsin, Milwaukee, WI
⁴The Medical College of Wisconsin/Children's Research Institute of the Children's Hospital of Wisconsin, Milwaukee, WI

Alette Glasø Skifjeld^1*, Beate Bjørnstad^1*, Yngvar Fløisand, MD, PhD^2* and Eline Aas, PhD^1*

¹Institute of Health and Society, University of Oslo, Oslo, Norway
²Department of Hematology, Oslo University Hospital, Oslo, Norway

Surbhi Sidana, MD¹, Paul Elson, PhD^2*, Aaron T. Gerds, MD, MS³, Hetty E. Carraway, MD, MBA³, Anjali S. Advani, MD³, Yogen Saunthararajah, M.D.³, Jaroslaw P. Maciejewski, MD, Ph.D.⁴, Matt Kalaycio, MD³, Mikkael A. Sekeres, MD, MS³ and Sudipto Mukherjee, MD, PhD³

¹Department of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN
²Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
³Leukemia Program, Cleveland Clinic, Cleveland, OH
⁴Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Juliana Martinez Rolon, MD^1*, Helen Baldomero^2*, Gregorio Jaimovich, MD^3*, Maria Rivas, MD^4*, Luis Fernando Bouzas, MD, MSC, PhD⁵, Carmem Maria Sales Bonfim, MD^6*, Julia Palma, MD^7*, Amado Karduss-Urueta, MD^8*, Diana Ubidia, MD^9*, Willem Bujan-Boza, MD^10*, Oscar Gonzalez-Ramella, MD^11*, Guillermo J. Ruiz-Arguelles, MD, FRCP (Glasg), MACP¹², David Gomez-Almaguer, MD¹³, German A. Espino, MD¹⁴, Ernesto Fanilla, MD^15*, Derlis Gonzalez, MD^16*, Antonio Carrasco, MD^17*, Sebastian Galeano, MD¹⁸, Walter Gabriel Borelli, MD^19*, Marcos Hernandez Gimenez, MD^20*, Marcelo C. Pasquini, MD, MS²¹, Yoshihisa Kodera, MD²², Dietger Niederwieser, MD²³ and Adriana Seber, MD, MS^24,25

¹FUNDALEU, Buenos Aires, Argentina
²Activity Survey Coordinator, WBMT, Basel, Switzerland
³Fundacion Favaloro, Buenos Aires, Argentina
⁴Hospital Universitario Austral, Buenos Aires, Argentina
⁵Divisão de Laboratórios CEMO/INCA - Lab Célula-tronco, Instituto Nacional de Cancer (INCA), Rio de Janeiro, Brazil
⁶Bone Marrow Transplantation unit, Federal University of Paraná, Curitiba, Brazil
⁷Hospital Dr Luis Calvo Mackenna, Santiago, Chile
⁸Instituto de Cancerologia, Medellin, Colombia
⁹instituto Nacional de donacion y trasplante de organos tejidos y celulas - INDOT, Pompillo Llona, Ecuador
¹⁰Hospital CIMA, San Jose, Costa Rica
¹¹University of Guadalajara, Guadalajara, Mexico
¹²Clinica Ruiz, Centro de Hematología y Medicina Interna, Puebla, Mexico
¹³Servicio de Hematologia, Hospital Universitario Dr. Jose Eleuterio Gonzalez Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
¹⁴Centro Hemato-Oncologia Paitilla, Panama City, Panama
¹⁵Instituto Oncologico Nacional, Panama, Panama
¹⁶Instituto de Prevision Social, Assuncion, Paraguay
¹⁷Instituto Nacional de Salud del Niño San Borja, Lima, Peru
¹⁸British Hospital, Montevideo, Uruguay
¹⁹Hematology and Stem Cell Transplantation Department, Hospital Maciel - A.S.S.E., Montevideo, Uruguay
²⁰Universidad de Carabobo MPPS, Valencia, Venezuela
²¹Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research, Milwaukee, WI
²²Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan
²³Hematology and Oncology, University Leipzig, Leipzig, Germany
²⁴Pediatric Hematopoietic Stem Cell Transplantation, Hospital Samaritano, Sao Paulo, Brazil
²⁵Latin American Bone Marrow Transplantation Group (LABMT), Sao Paulo, Brazil

Jessica El-Asmar, M.D.^1*, Tea Reljic, MPH^2*, Ernesto Ayala, M.D.^3,4*, Taiga Nishihori, M.D.^3,4*, Mehdi Hamadani, M.D.^5*, Ambuj Kumar, M.D., MPH^2* and Mohamed A. Kharfan-Dabaja, M.D.^4,6

¹Dept. of Internal Medicine, American Univ. of Beirut, Beirut, Lebanon
²Center for Evidence-Based Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL
³Dept. of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
⁴Dept. of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL
⁵Dept. of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁶Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL

Sanghee Hong, MD¹, Lisa A. Rybicki, MS^2*, Donna M Abounader^3*, Brian J. Bolwell, MD⁴, Robert M. Dean, MD⁵, Aaron T. Gerds, MD, MS⁶, Betty K. Hamilton, MD^4,5, Brian T. Hill, MD, PhD⁵, Deepa Jagadeesh, MD, MPH⁷, Matt Kalaycio, MD⁶, Hien K. Liu, MD⁵, Brad Pohlman, MD³, Ronald Sobecks, MD³ and Navneet S. Majhail, MD, MS⁴

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH
³Blood and Marrow Transplant, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁵Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁶Leukemia Program, Cleveland Clinic, Cleveland, OH
⁷Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH

Tito R. Mendoza, PhD^1*, Amylou C. Dueck, PhD², Qiuling Shi, PhD^1*, Haijun Ma, PhD^3*, Jeffrey Zhang, PhD^3*, Yi Qian, PhD^4* and Charles S. Cleeland, PhD^1*

¹Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX
²Mayo Clinic, Scottsdale, AZ
³Amgen Inc., Thousand Oaks, CA
⁴Amgen, Inc, Thousand Oaks, CA

Thomas W. LeBlanc, MD, MA^1,2, Steven P Wolf, MS^3*, Areej El-Jawahri, MD⁴, Debra M Davis, RN, MSEd^3*, Susan C Locke, PhD^3* and Amy Abernethy, MD, PhD^5*

¹Duke Cancer Institute, Durham, NC
²Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
³Center for Learning Health Care, Duke Clinical Research Institute, Durham, NC
⁴Massachusetts General Hospital/Harvard Medical School, Boston, MA
⁵Duke University School of Medicine, Durham, NC

May Hagiwara, PhD^1*, Aaron Moynahan, MA^1*, Ze Cong^2*, Yaozhu J. Chen, MPA^2*, Emilie Duchesneau, BA^1*, Dana Hurley, PharmD, MS^3* and Thomas E. Delea, MSIA^1*

¹Policy Analysis Inc. (PAI), Brookline, MA
²Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
³Onyx Pharmaceuticals, Inc., an Amgen subsidiary, Seattle, WA

Saad Usmani^1*, Tahamtan Ahmadi², Yvette Ng^3*, Annette Lam^3*, Ravi Potluri^4* and Maneesha Mehra^3*

¹Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC
²Janssen Research & Development, LLC, Spring House, PA
³Janssen Global Services, LLC, Raritan, NJ
⁴SmartAnalyst, Inc., New York, NY

Nathan J. Schloemer, MD^1*, Melissa A. Acquazzino, MD^1*, Deb Schmidt, RN, MSN, APNP^2*, Lynnette Anderson, RN, MSN, APNP^1*, Richard L. Tower II, MD, MS¹ and J. Paul Scott, MD¹

¹MACC Fund Center, Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI
²MACC Fund Center, Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Children's Hospital of Wisconsin, Milwaukee, WI

Ariel Berger, MPH^1*, Walter W Grubb, MS^2*, Samuel Huse^1*, Maitreyee Mohanty, MPharm PhD^1*, John Ferraro, MBA^2*, Moya Daniels, MS^2* and Wendy J. Levin, MD MS²

¹Evidera, Lexington, MA
²Fate Therapeutics, Inc, San Diego, CA

Yi Qian, PhD^1*, Debajyoti Bhowmik, B.Pharm, PhD^1*, Nandita Kachru, MS^1,2*, Rohini K. Hernandez, PhD^1*, Paul Cheng, MD, PhD^3* and Alexander Liede, BSc, MSc, PhD^1*

¹Amgen, Inc, Thousand Oaks, CA
²College of Pharmacy, University of Houston, Houston, TX
³Amgen Inc., Thousand Oaks, CA

Jesse Keller, MD^1,2, Kristen M. Sanfilippo, MD, MPHS^2,3, Suhong Luo, MPH^2*, Brian F. Gage, MD, MSc^4* and Kenneth R Carson, MD, PhD^5,6

¹Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
²Research Service, St Louis Veterans Administration Medical Center, St Louis, MO
³Division of Hematology, Washington University School of Medicine, Saint Louis, MO
⁴Department of Medicine, Washington University Medical School, Saint Louis, MO
⁵Washington University School of Medicine, Saint Louis, MO
⁶Medicine, St Louis Veterans Administration Medical Center, St Louis, MO

Giuseppe Gritti, MD^1*, Paola Stefanoni, MD^2*, Cristina Boschini, MSc^2*, Andrea Rossi, MD^2*, Anna Maria Barbui, MD^1* and Alessandro Rambaldi, MD²

¹Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
²Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

Istvan Majer^1*, Arun Krishna^2*, Gijs van de Wetering^1*, Jesús F. San-Miguel, MD, PhD³ and Paul G. Richardson⁴

¹Pharmerit International, Rotterdam, Netherlands
²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³Clinica Universidad de Navarra, Pamplona, Spain
⁴Dana-Farber Cancer Institute, Boston, MA

Feng-Kui Zhang^1*, Xiao-Fan Zhu^2*, Hai-Long He^3*, Shun-Qing Wang^4*, Jing-Yan Tang^5*, Dao-Bin Zhou^6*, Dong-Hua Zhang^7*, Yu-Hong Zhou^8*, De-pei Wu⁹, Wei Li^10*, Ling-Hui Xia^11*, Huan-Ling Zhu^12*, Feng Liu^13*, Hong-Xia Shi^14*, Xi Zhang^15*, Fang Zhou^16*, Jian-Da Hu^17*, Jian-Pei Fang^18*, Xie-Qun Chen^19*, Tie-Zhen Ye^20*, Ying-Min Liang^21* and Jie Jin^22*

¹Department of Anemia Therapeutic Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College (CAMS & PUMC), Tianjin, China
²Diagnosis and Treatment Center of Pediatric Blood Diseases, Institute of Hematology and Blood Disease Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Tianjin, China
³Department of Hematology and Oncology, Soochow University Affiliated Children's Hospital, Suzhou, China
⁴Department of Adult Hematology, Guangzhou First People's Hospital, Guangzhou, China
⁵Department of Hematology and Oncology, Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
⁶Department of Adult Hematology, Peking Union Medical College Hospital, Beijing, China
⁷Department of Adult Hematology, Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology, Wuhan, China
⁸The First Affiliated Hospital, Zhejiang University of Traditional Chinese Medicine, Hangzhou, China
⁹Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
¹⁰Department of Hematology, The First Hospital of Jilin University, Changchun, China
¹¹Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan China, Tianjin, China
¹²Department of Adult Hematology, West China Hospital, Sichuan University, Chengdu, China
¹³Department of Adult Hematology, Xiyuan Hospital, Chinese Academy of Chinese Medicine Sciences Peking University People's Hospital, Beijing, China
¹⁴Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
¹⁵Department of Adult Hematology, Xinqiao Hospital, Third Military Medical University, Chongqing, China
¹⁶Department of Adult Hematology, Jinan Military General Hospital, Jinan, China
¹⁷Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
¹⁸Department of Pediatric Hematology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
¹⁹Department of Hematology, Xijing Hospital, Xi'an, China
²⁰Department of Pediatric Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, China
²¹Department of Hematology, Tangdu Hospital, Xi'an, China
²²Department of Adult Hematology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China

Robert M. Rifkin¹, Esprit Ma, MPH^2*, Robyn Harrell, MS^3*, Yanyan Zhu, PhD, MPH^2*, Edward Dow, MD^4*, Liviu Niculescu, MD, PhD^2* and Vijayveer Bonthapally, PhD^2*

¹Rocky Mountain Cancer Center, McKesson Specialty Health/US Oncology Network, Denver, CO
²Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
³McKesson Specialty Health/US Oncology Network, Woodlands, TX
⁴Foundation Medicine, Cambridge, MA

Jeffrey E Lancet, MD¹, Phillip Cyr, MPH^2*, Naomi Sacks, PhD^2*, Michael T. Chiarella^3*, Arthur C. Louie, MD³ and Jorge E. Cortes, MD⁴

¹Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Precision for Value, Cambridge, MA
³Celator Pharmaceuticals, Inc., Ewing, NJ
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Lakshmi Radhakrishnan, MPH^1*, Sagar Lonial, MD^2,3 and Ajay K. Nooka, MD, MPH¹

¹Division of BMT, Winship Cancer Institute, Emory University, Atlanta, GA
²Winship Cancer Institute, Emory University, Atlanta, GA
³Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA

Bruce Feinberg, DO^1*, Brad Schenkel, MSc^2*, Ali McBride, PharmD, MS³, Lorie Ellis, PhD^2*, Menaka Bhor^1*, Janna Radtchenko^1* and Lincy S Lal^1*

¹Cardinal Health, Dublin, OH
²Janssen Scientific Affairs, LLC, Horsham, PA
³University of Arizona Cancer Center, Tucson, AZ

Neeraj Sidharthan, MD, DM^1*, Rema Ganapathy, DNB^2*, P Gangadharan, MSc MS^3*, Sumi Soman, BSc^4*, Keechilet Pavithran, MD, DM^2*, Raghuveer Prabhu, MD, DM^2*, Haripriya V Raju, MSW^5*, Ayswarya Rajan, BSc^2*, Pavankumar Boyella, MD, DM^2*, Rajeswari Arun, MBBS FAAP^6*, Scott C. Howard, MD⁷ and Asha Pillai, MD⁸

¹Department of Medical Oncology & Hematology and Department of BMT, Amrita Institute of Medical Sciences, Kochi, India
²Department of Medical Oncology and Hematology, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
³Cancer Registry, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
⁴Department of Public Health Research, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
⁵Department of Medical Social Work, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
⁶Department of Pediatrics, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
⁷School of Health Sciences, University of Memphis, Memphis, TN
⁸Department of BMT & Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN

Sarah K Kraus, PharmD^1*, Catherine E Burdalski, PharmD^1*, Colleen Timlin, PharmD, BCOP^2*, Tracy M Krause, PharmD, BCOP^1*, Todd A Miano, PharmD, MSCE^3*, Jakub Svoboda, MD⁴ and Alex Ganetsky, PharmD, BCOP^1*

¹Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA
²Department of Pharmacy, Hospital of The University of Pennsylvania, Philadelphia, PA
³Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁴Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Kailash Mosalpuria, MD, MPH¹, Vijaya R. Bhatt, MD² and Lata Nawal, MPH^3*

¹Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
²Hematology-Oncology, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE
³Department of Epidemiology, University Of Nebraska Medical Center, Omaha, NE

Bindu Kanathezhath, M.D., FAAP^1,2, Amritha Radhakrishnan, MS^3*, Sujith Kumar, MD^2,4* and Narayanankutty Warrier, DM^2*

¹Pediatric Hematology, Community Medical Center, Vacaville, CA
²Medical Oncology Center, Malabar Institute of Medical Sciences, Calicut, India
³National Institute of Research in Tuberculosis, Indian Council of Medical Research, Chennai, India
⁴Medical Oncology, Tata Memorial Center, Mumbai, India

Jakub Radocha, MD, PhD^1,2*, Ludek Pour, MD, PhD^2,3*, Ivan Spicka, MD, PhD^2,4*, Vlastimil Scudla, MD, PhD^2,5*, Evzen Gregora, MD^2,6*, Hana Frankova, MD^2,7*, Roman Hajek, MD^2,8, Miroslava Schutzova, MD^2,9*, Michal Sykora, MD^2,10*, Petr Kessler, MD^2,11*, Dagmar Adamova, MD^2,12*, Marek Wrobel, MD^2,13*, Lenka Sedlarikova, MSc^2,14*, Sabina Sevcikova, RNDr, PhD^2,15, Daniel Horinek, MSc^2*, Jana Pelcova, Bc^2*, Lucie Brozova, Mgr^2,16*, Jiri Jarkovsky, MSc, PhD^2,16* and Vladimir Maisnar, MD, PhD^1,2*

¹4th Department of Medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
²Czech Myeloma Group, Brno, Czech Republic
³University Hospital Brno, Brno, Czech Republic
⁴1st Medical Department – Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital, Charles University, Prague, Czech Republic
⁵Department of Hematooncology, University Hospital, Olomouc, Czech Republic
⁶University Hospital Kralovske Vinohrady, Prague 10, Czech Republic
⁷Department of Clinical Hematology, Nemocnice Liberec, Liberec, Czech Republic
⁸Department of Clinical Hematology, University Hospital Ostrava, Ostrava, Czech Republic
⁹Department of hematooncology, University Hospital Plzen, Plzen, Czech Republic
¹⁰Department of Clinical Hematology, Nemocnice Ceske Budejovice, Ceske Budejovice, Czech Republic
¹¹Pelhrimov Hospital, Pelhrimov, Czech Republic
¹²Department of Hematology and Transfusion, Nemocnice Opava, Opava, Czech Republic
¹³Department of Oncology, Nemocnice Novy Jicin, Novy Jicin, Czech Republic
¹⁴LF Masaryk University, Brno, Czech Republic
¹⁵Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
¹⁶Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Dorothy Romanus, RPh, MSc, PhD^1*, Mehul Jhaveri, PharmD, PhD^1*, Richard Labotka, MD, MS¹, Henry Henk, PhD^2* and Brian Seal, RPh, MBA, PhD^1*

¹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²HEOR, Optum, Eden Prairie, MN

Dorothy Romanus, RPh, MSc, PhD^1*, Brian Seal, RPh, MBA, PhD^1*, Mehul Jhaveri, PharmD, PhD^1*, Richard Labotka, MD, MS¹ and Henry Henk, PhD^2*

¹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²HEOR, Optum, Eden Prairie, MN

Amanda Shreders, MD¹, Shehzad Niazi, MD^2*, David Hodge^2*, Nicolette Chimato^2*, Megha Kureti^2*, Navya Kirla^2*, Abhisek Swaika, MBBS^3*, Elaine Gustetic^2*, Renee Foster^2*, Kimberly Nelson^2*, Asher Chanan-Khan, MD⁴ and Sikander Ailawadhi, MD¹

¹Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL
²Mayo Clinic, Jacksonville, FL
³Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
⁴Division of Hematology, Mayo Clinic, Jacksonville, FL

Guru Subramanian Guru Murthy, MD¹, Jeannette Lee, PHD^2* and Paulette Mehta, MD, MPH³

¹Hematology, Medical College of Wisconsin, Milwaukee, WI
²Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR
³Internal Medicine/Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, AR

Eric Maiese^1*, Brian Macomson, PharmD^2*, Chris Kozma^3*, Terra Slaton^4* and Mekre Senbetta, PharmD^5*

¹HECOR, Janssen Scientific Affairs, LLC, Horsham, PA
²Janssen Scientific Services, LLC, Augusta, GA
³CK Consulting Associates, LLC, St. Helena Island, SC
⁴HECOR, CK Consulting Associates, LLC, St. Helena Island, SC
⁵Janssen, Horsham, PA

Victoria Divino, BA^1*, Sudeep Karve, PhD^2*, Andrew Gaughan, MSc^2*, Mitch DeKoven, MHSA^1*, Guozhi Gao^3* and Mark Lanasa, MD, PhD⁴

¹IMS Health, Fairfax, VA
²AstraZeneca, Gaithersburg, MD
³MedImmune, Gaithersburg, MD
⁴Clinical Development, Oncology, MedImmune, Gaithersburg, MD

Nicole Princic^1*, Chris Gregory^2*, Tina Willson^3*, Maya Mahue^4*, Diana Felici^4*, Winifred Werther^4*, Gregory Lenhart^5* and Kathy Foley^6*

¹Truven Health, Reading, PA
²Truven Health, Woodbridge, MA
³Truven Health, Salt Lake City, UT
⁴Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
⁵Truven Health, Lexington, MA
⁶Pfizer, Inc., Collegeville, PA

María Fuentes-Garí, PhD^1*, Sophie Zemenides, MBBS, MRCP, MSc, BSc^2*, Ruth Misener, PhD^3*, Michael C. Georgiadis, PhD^4*, Efstratios N. Pistikopoulos, PhD^5*, Athanasios Mantalaris, PhD^1* and Nicki Panoskaltsis, MD, PhD⁶

¹Department of Chemical Engineering, Imperial College London, London, United Kingdom
²Imperial College London, London, United Kingdom
³Computing, Imperial College London, London, United Kingdom
⁴Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
⁵Artie McFerrin Department of Chemical Engineering, Texas A&M University, Austin, TX
⁶Department of Hematology, Imperial College London, London, United Kingdom

Shruti Kusumgar, MBA^1*, Kevin Johnson^2*, Monica Belford^2*, Avinash Desai, MD¹ and Jianming He, PhD^3*

¹Janssen, Raritan, NJ
²Marketeching, Flemington, NJ
³Janssen Global Services, LLC, Raritan, NJ

Meir Preis, MD, PhD¹, Ziad Abu-Salah^2*, Ravit Melberger^3*, Leah Zack^3*, Judith Mohilever^4*, Limor Cohen^4*, Judith Shwartz^4*, Shai Cohen, MD^2*, Ophir Lavon, MD^5*, Yamit Musai^5* and Sharon Alroy Preis, MD, MPH^5*

¹Hematology, Lady Davis Carmel Medical Center, Haifa, Israel
²Inpatient Depatment B, Lady Davis Carmel Medical Center, Haifa, Israel
³Pharmacy, Lady Davis Carmel Medical Center, Haifa, Israel
⁴IT Division, Lady Davis Carmel Medical Center, haifa, Israel
⁵Quality and Patient Safety Division, Lady Davis Carmel Medical Center, Haifa, Israel

Michelle K. White^1*, Martha Bayliss^1*, Muriel Finkel^2*, Isabelle Lousada^3* and Spencer Guthrie^4*

¹Optum, Lincoln, RI
²Amyloidosis Support Group, Itasca, IL
³Amyloidosis Foundation, Boston, MA
⁴Prothena Biosciences Inc, South San Francisco, CA

Bruce Feinberg, DO^1*, Brad Schenkel, MSc^2*, Ali McBride, PharmD, MS³, Lorie Ellis, PhD^2*, Menaka Bhor^1*, Janna Radtchenko^1* and Lincy S Lal^1*

¹Cardinal Health, Dublin, OH
²Janssen Scientific Affairs, LLC, Horsham, PA
³University of Arizona Cancer Center, Tucson, AZ

Kristen M Rosenthal, PhD^1*, Christopher R. Flowers, MD², Andre Goy, MD³, John P. Leonard, MD⁴, Julie M. Vose, M.D.⁵, Erik D. Brady, PhD, CHCP^1*, Jim Mortimer^1*, Kevin L Obholz, PhD^1* and James O. Armitage, MD⁶

¹Clinical Care Options, LLC, Reston, VA
²Winship Cancer Institute, Emory University, Atlanta, GA
³John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁴Department of Medicine, Weill Cornell Medical College, New York, NY
⁵Internal Medicine Section of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
⁶Department of Internal Medicine, Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE

Stacey Dacosta Byfield, PhD, MPH¹, Nicole Engel-Nitz, PhD^1*, Timothy Bancroft, PhD^1*, Amy J Anderson, MS^1*, Carolina Reyes, PhD^2*, Arliene Ravelo, MPH^2*, Sarika Ogale, PhD^2*, May Chen, MD^3* and Matthew J. Matasar, MD, MS⁴

¹Health Economics and Outcomes Research, Optum, Eden Prairie, MN
²Genentech, Inc., South San Francisco, CA
³Southbay Oncology Hematology Partners, Campbell, CA
⁴Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY

Alison Romisher^1*, Joseph Carver, MD^1*, Stephen J. Schuster, MD¹, Jakub Svoboda, MD¹, Alexandra Vandegrift, BA^1*, Allison Rago, BSN^1*, Rupal O'Quinn, MD^1*, Bonnie Ky, MD^1* and Anthony R. Mato, MD^2*

¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Center for Chronic Lymphocytic Leukemia, University of Pennsylvania, Philadelphia, PA

Thomas Gregory Knight, MD^1*, Joshua F. Zeidner, MD², Naim U Rashid, PhD^3* and Matthew C Foster, MD⁴

¹University of North Carolina, Chapel Hill, NC
²Department of Medicine, University of North Carolina, Chapel Hill, NC
³Lineberger Comprehensive Cancer Center, Chapel Hill, NC
⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill